BioLineRx Ltd.
BLRX
$3.34
-$0.13-3.75%
NASDAQ
Rating
Reward
Risk
Rating Factors
Growth Index
Efficiency Index
Solvency Index
Total Return Index
Volatility Index
Dividend Index
Headlines
6/6/2025
-
MarketBeat
11/26/2025
-
TipRanks Financial Blog
11/25/2025
-
TipRanks Financial Blog
11/24/2025
-
Seeking Alpha - Israel Stocks
11/24/2025
-
Seeking Alpha: Transcripts
11/24/2025
-
SeekingAlpha
11/24/2025
-
TipRanks Financial Blog
11/24/2025
-
GuruFocus
11/24/2025
-
GuruFocus
11/24/2025
-
GuruFocus
11/24/2025
-
The Fly
11/24/2025
-
PR Newswire
11/21/2025
-
Seeking Alpha - Israel Stocks
11/18/2025
-
GuruFocus
11/18/2025
-
PR Newswire
11/17/2025
-
GuruFocus
11/17/2025
-
PR Newswire
10/15/2025
-
Ticker Report
9/30/2025
-
Pharmaceutical Business Review
9/29/2025
-
SeekingAlpha
9/29/2025
-
Seeking Alpha - Israel Stocks
9/29/2025
-
Seeking Alpha: Transcripts
9/29/2025
-
GuruFocus
9/29/2025
-
GuruFocus
9/29/2025
-
TipRanks Financial Blog
Income Statement
Total Revenue (TTM)
EBITDA (TTM)
EBIT (TTM)
Net Income (TTM)
Balance Sheet
Total Assets (Q)
Total Debt (Q)
Total Liabilities (Q)
Book Value Per Share (Q)
Cash Flow
Cash from Operations (TTM)
Cash from Investing (TTM)
Cash from Financing (TTM)
Net Change in Cash (TTM)
Filings
Filing Date
Monday, November 24, 2025
Period Date
Tuesday, September 30, 2025
Next Filing
End of March (est)
Price History
Beta
7-Day Total Return
30-Day Total Return
60-Day Total Return
90-Day Total Return
Year to Date Total Return
1-Year Total Return
2-Year Total Return
3-Year Total Return
5-Year Total Return
52-week Low
52-week High
Valuation
Enterprise Value
Price/Sales (TTM)
Price/Book (Q)
Dividends and Shares
Shares Outstanding
Dividend Per Share (Most Recent)
--
Dividend Per Share (TTM)
--
Corporate Info
Website
Phone Number
972 8 642 9100
Address
Modi’in Technology Park
Hevel Modi'in, 7177871
Hevel Modi'in, 7177871
Country
Year Founded
Business Description
Sector
BioLineRx Ltd., a commercial stage biopharmaceutical company, develops and commercializes therapeutics for oncology and rare diseases. The company’s pipeline includes APHEXDA (motixafortide), a...
more